| A novel multiple-stage antimalarial agent that inhibits protein synthesis B Baragaña, I Hallyburton, MCS Lee, NR Norcross, R Grimaldi, TD Otto, ... Nature 522 (7556), 315-320, 2015 | 461 | 2015 |
| Quinolone-3-diarylethers: a new class of antimalarial drug A Nilsen, AN LaCrue, KL White, IP Forquer, RM Cross, J Marfurt, ... Science translational medicine 5 (177), 177ra37-177ra37, 2013 | 252 | 2013 |
| Identifying purine nucleoside phosphorylase as the target of quinine using cellular thermal shift assay JM Dziekan, H Yu, D Chen, L Dai, G Wirjanata, A Larsson, N Prabhu, ... Science translational medicine 11 (473), eaau3174, 2019 | 190 | 2019 |
| KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission KL Kuhen, AK Chatterjee, M Rottmann, K Gagaring, R Borboa, ... Antimicrobial agents and chemotherapy 58 (9), 5060-5067, 2014 | 175 | 2014 |
| Pyrazoleamide compounds are potent antimalarials that target Na+ homeostasis in intraerythrocytic Plasmodium falciparum AB Vaidya, JM Morrisey, Z Zhang, S Das, TM Daly, TD Otto, NJ Spillman, ... Nature communications 5 (1), 5521, 2014 | 154 | 2014 |
| Cellular thermal shift assay for the identification of drug–target interactions in the Plasmodium falciparum proteome JM Dziekan, G Wirjanata, L Dai, KD Go, H Yu, YT Lim, L Chen, LC Wang, ... Nature protocols 15 (6), 1881-1921, 2020 | 90 | 2020 |
| A triazolopyrimidine-based dihydroorotate dehydrogenase inhibitor with improved drug-like properties for treatment and prevention of malaria MA Phillips, KL White, S Kokkonda, X Deng, J White, F El Mazouni, ... ACS infectious diseases 2 (12), 945-957, 2016 | 88 | 2016 |
| A tetraoxane-based antimalarial drug candidate that overcomes PfK13-C580Y dependent artemisinin resistance PM O’Neill, RK Amewu, SA Charman, S Sabbani, NF Gnädig, J Straimer, ... Nature Communications 8 (1), 15159, 2017 | 71 | 2017 |
| UCT943, a next-generation Plasmodium falciparum PI4K inhibitor preclinical candidate for the treatment of malaria C Brunschwig, N Lawrence, D Taylor, E Abay, M Njoroge, GS Basarab, ... Antimicrobial agents and chemotherapy 62 (9), 10.1128/aac. 00012-18, 2018 | 68 | 2018 |
| Submicroscopic and Asymptomatic Plasmodium Parasitaemia Associated with Significant Risk of Anaemia in Papua, Indonesia Z Pava, FH Burdam, I Handayuni, L Trianty, RAS Utami, YK Tirta, ... PloS one 11 (10), e0165340, 2016 | 65 | 2016 |
| Characterization of novel antimalarial compound ACT-451840: preclinical assessment of activity and dose–efficacy modeling A Le Bihan, R de Kanter, I Angulo-Barturen, C Binkert, C Boss, R Brun, ... PLoS medicine 13 (10), e1002138, 2016 | 46 | 2016 |
| Comparative Ex Vivo Activity of Novel Endoperoxides in Multidrug-Resistant Plasmodium falciparum and P. vivax J Marfurt, F Chalfein, P Prayoga, F Wabiser, G Wirjanata, B Sebayang, ... Antimicrobial agents and chemotherapy 56 (10), 5258-5263, 2012 | 45 | 2012 |
| Effective Preparation of Plasmodium vivax Field Isolates for High-Throughput Whole Genome Sequencing S Auburn, J Marfurt, G Maslen, S Campino, V Ruano Rubio, M Manske, ... PLoS One 8 (1), e53160, 2013 | 37 | 2013 |
| The antimalarial MMV688533 provides potential for single-dose cures with a high barrier to Plasmodium falciparum parasite resistance JM Murithi, C Pascal, J Bath, X Boulenc, NF Gnädig, CFA Pasaje, ... Science translational medicine 13 (603), eabg6013, 2021 | 34 | 2021 |
| Expression of Plasmodium vivax crt-o Is Related to Parasite Stage but Not Ex Vivo Chloroquine Susceptibility Z Pava, I Handayuni, G Wirjanata, S To, L Trianty, R Noviyanti, ... Antimicrobial agents and chemotherapy 60 (1), 361-367, 2016 | 32 | 2016 |
| Potent Ex Vivo Activity of Naphthoquine and Methylene Blue against Drug-Resistant Clinical Isolates of Plasmodium falciparum and Plasmodium vivax G Wirjanata, BF Sebayang, F Chalfein, Prayoga, I Handayuni, L Trianty, ... Antimicrobial Agents and Chemotherapy 59 (10), 6117-6124, 2015 | 27 | 2015 |
| A comprehensive RNA handling and transcriptomics guide for high-throughput processing of Plasmodium blood-stage samples M Kucharski, J Tripathi, S Nayak, L Zhu, G Wirjanata, RW Van Der Pluijm, ... Malaria Journal 19, 1-16, 2020 | 23 | 2020 |
| 3, 3′-Disubstituted 5, 5′-bi (1, 2, 4-triazine) derivatives with potent in vitro and in vivo antimalarial activity L Xue, DH Shi, JR Harjani, F Huang, JG Beveridge, T Dingjan, K Ban, ... Journal of medicinal chemistry 62 (5), 2485-2498, 2019 | 19 | 2019 |
| Passively versus actively detected malaria: similar genetic diversity but different complexity of infection Z Pava, I Handayuni, L Trianty, RAS Utami, YK Tirta, AM Puspitasari, ... The American journal of tropical medicine and hygiene 97 (6), 1788, 2017 | 19 | 2017 |
| Quinolone-3-diarylethers: a new class of antimalarial drug. Sci Transl Med 5: 177ra37 A Nilsen, AN LaCrue, KL White, IP Forquer, RM Cross, J Marfurt, ... | 19 | 2013 |